Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm

Lina Pedraza Sanchez; Justin Hintze; Samantha Newman; Ashok Shaha; Luc G. Morris; R Michael Tuttle

doi:10.1002/hed.70279

April 16, 2026Head & Neck

Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm

View at Publisher

Ask AI

Bookmark

Share

Key Points

To evaluate the effectiveness of active surveillance as a management approach for papillary thyroid cancer (PTC) tumors larger than 1.5 cm.
Assessment of patients with PTC larger than 1.5 cm
Selection based on specific criteria for active surveillance
Longitudinal monitoring of tumor development and patient outcomes
Active surveillance is shown to be a viable management option for selected patients
Findings indicate no immediate need for aggressive treatment in observed cases
Patient outcomes remained stable under active surveillance over a defined period

Implication

Findings suggest active surveillance offers effective management for selected patients with larger papillary thyroid cancer tumors, indicating potential benefits.

Abstract

These findings suggest that active surveillance is a viable initial management option in properly selected patients with PTC greater than 1.5 cm in maximal diameter.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sanchez et al. (2026) studied this question.

synapsesocial.com/papers/69e474b6010ef96374d902f9 https://doi.org/10.1002/hed.70279

View at Publisher

Ask AI

Bookmark

Share

Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm

Key Points

Implication

Abstract

Discussion

Cite This Study

Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading